{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T15:04:19Z","timestamp":1770044659292,"version":"3.49.0"},"reference-count":32,"publisher":"Wiley","issue":"S274","license":[{"start":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T00:00:00Z","timestamp":1187827200000},"content-version":"vor","delay-in-days":10553,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Psychiatr Scand"],"published-print":{"date-parts":[[1978,10]]},"abstract":"<jats:p>The benzodiazepines have been available now for about 1.5 years but new aspects of their actions are being elucidated all the time. Oxazepani has a short half\u2010life and inactive metabolites and therefore differs from most other benzodiazepines. Some aspects of its clinical pharmacology are reviewed in outline. Firstly, the effects of the drug on psychological functioning is discussed. Next, the controversy regarding benzodiazepinea and aggression is examined. Oxazepam appears exceptional here in that it is not associated with paradoxical release of aggression in patients. Finally, the ethical implications of the widespread use of these drugs is commented on, and the problem of dependence, physical and psychological, discussed. It appears that oxazepam is less likely than other benzodiazepines to induce dependence.<\/jats:p>","DOI":"10.1111\/j.1600-0447.1978.tb02391.x","type":"journal-article","created":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T09:34:41Z","timestamp":1187861681000},"page":"89-93","source":"Crossref","is-referenced-by-count":5,"title":["The clinical pharmacology of oxazepam"],"prefix":"10.1111","volume":"58","author":[{"given":"M. H.","family":"LADER","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,10,15]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-197502000-00004"},{"key":"e_1_2_1_3_1","volume-title":"Interaction Process Analysis","author":"Bales R. F.","year":"1950"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197404042901404"},{"issue":"5","key":"e_1_2_1_5_1","first-page":"17","article-title":"A critical review of oxazepam: efficacy and specificity","volume":"36","author":"Blackwell B.","year":"1975","journal-title":"Dis. nerv. Syst."},{"key":"e_1_2_1_6_1","first-page":"427","article-title":"Pharmaceutical management of behavior disorders; chlordiazepoxide in covert and overt expressions of aggression","volume":"58","author":"Boyle D.","year":"1961","journal-title":"J. med. Soc. N. J."},{"key":"e_1_2_1_7_1","first-page":"543","article-title":"Effect of oxazepam on physiological responses to stress in normal subjects","volume":"10","author":"Brown M. L.","year":"1968","journal-title":"Curr. ther. Res."},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1037\/h0046900"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(65)72241-X"},{"key":"e_1_2_1_10_1","first-page":"283","volume-title":"Hypnotics","author":"Fabre L. F.","year":"1975"},{"key":"e_1_2_1_11_1","first-page":"754","article-title":"Psychophysiologische Untersuchung eines Tranquilizers nach kovarianzanalytischem Plan zur Kontrolle von Ausgangswerten und Pers\u00f6nlichkeits\u2010dimensionen","volume":"16","author":"Fahrenberg J.","year":"1966","journal-title":"Arzneimittel-Forsch."},{"key":"e_1_2_1_12_1","first-page":"S62","article-title":"An analysis of the efficacy of diazepam","volume":"3","author":"Feldman P. E.","year":"1962","journal-title":"J. Neuropsychiat."},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1968.01740060117014"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1965.01730040001001"},{"key":"e_1_2_1_15_1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1192\/S0007125000192931","article-title":"Diazepam in the management of epilepsy","volume":"777","author":"Goddard P.","year":"1970","journal-title":"Brit. J. Psychiat."},{"issue":"5","key":"e_1_2_1_16_1","first-page":"6","article-title":"Pharmacokinetics in clinical medicine: oxazepam versus other benzodiazepines","volume":"36","author":"Greenblatt D. J.","year":"1975","journal-title":"Dis. nerv. Syst."},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.120.557.443"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(60)91838-9"},{"key":"e_1_2_1_19_1","first-page":"101","article-title":"Diazepam: its role in a prison setting","volume":"25","author":"Kalina R. K.","year":"1964","journal-title":"Dis. nerv. Syst."},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.132.8.861"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(78)90098-2"},{"key":"e_1_2_1_22_1","first-page":"557","article-title":"\u201cParadoxical Rage Reactions\u201d during psychotropic medication","volume":"36","author":"Lion J. R.","year":"1975","journal-title":"Dis. nerv. Syst."},{"key":"e_1_2_1_23_1","first-page":"194","article-title":"Beobachtung einer Oxazepam\u2010Abhangigkeit","volume":"122","author":"Mader R.","year":"1972","journal-title":"Wien. med. Wschr."},{"key":"e_1_2_1_24_1","first-page":"4949","article-title":"Premedicinering med oxazepam i odontologisk praxis","volume":"64","author":"Nordenram \u00c5.","year":"1967","journal-title":"Lakartidningen"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(71)71536-9"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-196708000-00007"},{"key":"e_1_2_1_27_1","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1176\/ajp.1974.131.4.442","article-title":"Chlordiazepoxide and hostility in anxious outpatients","volume":"131","author":"Rickels K.","year":"1974","journal-title":"Amer. J. Psychiat."},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1974.01760150103015"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.198.8.951"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.134.6.652"},{"key":"e_1_2_1_31_1","first-page":"237","volume-title":"Drugs affecting the Central Nervous Sytem 2","author":"Sternbach L. H.","year":"1968"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1960.03030100010003"},{"key":"e_1_2_1_33_1","volume-title":"The Clinical Psychopharmacology of Anxiety","author":"Wittenborn J. R.","year":"1966"}],"container-title":["Acta Psychiatrica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0447.1978.tb02391.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0447.1978.tb02391.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T20:23:46Z","timestamp":1699475026000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0447.1978.tb02391.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1978,10]]},"references-count":32,"journal-issue":{"issue":"S274","published-print":{"date-parts":[[1978,10]]}},"alternative-id":["10.1111\/j.1600-0447.1978.tb02391.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0447.1978.tb02391.x","archive":["Portico"],"relation":{},"ISSN":["0001-690X","1600-0447"],"issn-type":[{"value":"0001-690X","type":"print"},{"value":"1600-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[1978,10]]}}}